Among several IDH1/2 mutant inhibitors, AG-120, AG-881, ML309, GSK321, and GSK864 exhibited remarkable anti-tumor activity [21], showing a significant histone and DNA demethylation activity in vitro. Here, IDH1 is linked to neoplasm.